| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |